cbdMD, Inc. (YCBD) Form 10-Q — May 14, 2026
cbdMD, Inc. reported a net loss of $1.1 million for the six months ended March 31, 2026, alongside a critical going-concern warning stating there is 'substantial doubt' about its ability to continue as a going concern within twelve months. The company holds only $2.6 million in cash against an accumulated deficit of $180.6 million, relying on a newly established $20 million equity line of credit (ELOC) and preferred stock financing to maintain liquidity. Revenue grew 8% year-over-year to $10.7 million, driven by a 19% sequential increase in the quarter and the January 2026 acquisition of Bluebird Botanicals for $937,000 in stock.
Key figures
- Revenue
- 10656964
- Total Debt
- 7321
- Revenue Yoy
- 8.1%
- Total Assets
- 12252849
- Cash Position
- 2638243
- Shares Outstanding
- 10497919
- Eloc capacity
- 20000000
- Accumulated deficit
- 180636537
- Bluebird acquisition value
- 936992
- Preferred stock dividend quarterly cash equivalent
- 70000
Price after filing
Close on the filing date to close N calendar days later (from $0.81). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.